The reiteration of a Buy rating and maintenance of a price target by a reputable analyst typically instills confidence in investors and can lead to a positive short term impact on the stock price. The specific mention of Genmab and the reaffirmation of the price target suggest a strong endorsement of the company's stock, which could influence investor sentiment and stock performance in the short term.